elder law weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of elder law weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Brigham and Women's Hospital
Option granted for rights to blood platelet modification technology
June 23rd, 2004
Brigham and Women's Hospital (BWH), and ZymeQuest, Inc., announced that BWH has granted ZymeQuest an option to license the worldwide rights to a new method of treating and chilling blood platelets that may prolong their shelf life by a week or more. The development of this technology was conducted by BWH's Department of Hematology with scientific support and assistance from ZymeQuest. Under a joint invention agreement, BWH and ZymeQuest share the proprietary rights to the technology. Platelets do not tolerate refrigeration. When subjected to chilling during storage for even very short periods of time, platelets disappear rapidly from the circulation...
Source: elder law weekly (2004-06-23)
|
